These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3481627)

  • 21. Variable tolerance of a clinical isolate of Staphylococcus epidermidis from an infected hydrocephalus shunt for several beta-lactam antibiotics, vancomycin and fosfomycin.
    Traub WH
    Chemotherapy; 1981; 27(6):432-43. PubMed ID: 7297172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of the bactericidal activity of the combination of fosfomycin with other antibiotics by 2 different methods (checkboard and bactericidal curves)].
    Gialdroni Grassi G; Ferrara A; Peona V; Colombo ML
    G Ital Chemioter; 1983; 30(2-3):77-84. PubMed ID: 6376256
    [No Abstract]   [Full Text] [Related]  

  • 23. [Dependence of the bactericidal activity and mutant selection of 4-quinolones on their serum concentration levels].
    Bauernfeind A; Petermüller C; Heinrich B; Gablac R
    Infection; 1986; 14 Suppl 1():S26-30. PubMed ID: 3082765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vitro activity of imipenem combined with beta-lactam antibiotics for methicillin-resistant Staphylococcus aureus.
    Matsuda K; Asahi Y; Sanada M; Nakagawa S; Tanaka N; Inoue M
    J Antimicrob Chemother; 1991 Jun; 27(6):809-15. PubMed ID: 1938687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Synergy, addition, indifference, antagonism and dominance. Dominance and antibiotic combination].
    Drugeon HB; Dellamonica P; Caillon J
    Pathol Biol (Paris); 1987 May; 35(5):495-500. PubMed ID: 3302851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of fosfomycin in a synergistic combination with ofloxacin against Pseudomonas aeruginosa growing in a biofilm.
    Monden K; Ando E; Iida M; Kumon H
    J Infect Chemother; 2002 Sep; 8(3):218-26. PubMed ID: 12373484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters.
    Simon VC; Simon M
    Scand J Infect Dis Suppl; 1990; 72():14-9. PubMed ID: 2151061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus].
    Fukuoka T; Domon H; Kakuta M; Ishii C; Hirasawa A; Utsui Y; Ohya S; Yasuda H
    Jpn J Antibiot; 1997 Apr; 50(4):411-9. PubMed ID: 9192249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of simulated serum concentrations of daptomycin versus vancomycin during the first 24h of treatment in the presence of physiological albumin concentrations against vancomycin-susceptible, -tolerant or -intermediate-resistant Staphylococcus aureus.
    Torrico M; Aguilar L; Sevillano D; Giménez MJ; Alou L; González N; Cafini F; Cleeland R; Prieto J
    Int J Antimicrob Agents; 2011 Apr; 37(4):332-8. PubMed ID: 21388792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.
    Graninger W; Leitha T; Breyer S; Francesconi M; Lenz K; Georgopoulos A
    Drugs Exp Clin Res; 1985; 11(1):23-7. PubMed ID: 3869801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cefotaxime in combination with other antibiotics for the treatment of severe methicillin-resistant staphylococcal infections.
    Portier H; Kazmierczak A; Lucht F; Tremeaux JC; Chavanet P; Duez JM
    Infection; 1985; 13 Suppl 1():S123-8. PubMed ID: 3850854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fosfomycin Enhances the Activity of Daptomycin against Vancomycin-Resistant Enterococci in an In Vitro Pharmacokinetic-Pharmacodynamic Model.
    Hall Snyder AD; Werth BJ; Nonejuie P; McRoberts JP; Pogliano J; Sakoulas G; Yim J; Singh N; Rybak MJ
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5716-23. PubMed ID: 27431211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ofloxacin: bactericidal effect in an in vitro pharmacokinetic model.
    Xerri L; Broggio R; Guerra L
    Chemioterapia; 1986 Apr; 5(2):83-7. PubMed ID: 3085961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibacterial activities and electron microscopic studies of imipenem in combination with fosfomycin against methicillin and fosfomycin resistant strains of Staphylococcus aureus].
    Saionji K; Shitara S; Kobayashi I
    Jpn J Antibiot; 1990 Mar; 43(3):379-87. PubMed ID: 2374289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of pharmacokinetics and bactericidal activity of teicoplanin and vancomycin.
    Lagast H; Dodion P; Klastersky J
    J Antimicrob Chemother; 1986 Oct; 18(4):513-20. PubMed ID: 2945811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.
    Tsuji BT; Rybak MJ
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2735-45. PubMed ID: 15980344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro study of the effects of an imipenem-fosfomycin combination against clinical strains of Staphylococcus].
    Fosse T; David MF; Duluc F
    Pathol Biol (Paris); 1986 Dec; 34(10):1055-9. PubMed ID: 3547260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In vitro effect of combinations of netilmicin and amikacin with fosfomycin and pefloxacin on 31 strains of heterogeneous methicillin- resistant Staphylococcus aureus].
    David C; Chaste A; Saison C; Combremont AG
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):608-12. PubMed ID: 3054735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vancomycin and piperacillin-tazobactam against methicillin-resistant Staphylococcus aureus and vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
    Dilworth TJ; Leonard SN; Vilay AM; Mercier RC
    Clin Ther; 2014 Oct; 36(10):1334-44. PubMed ID: 25066667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum bactericidal activity of ciprofloxacin and ofloxacin in volunteers.
    Machka K; Milatovic D
    Eur J Clin Microbiol; 1987 Feb; 6(1):59-62. PubMed ID: 3106034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.